Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek ® Guide Link blood glucose meter. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian ™ Sensor (3).Īll therapy adjustments should be based on measurements obtained using the Accu-Chek ® Guide Link blood glucose meter and not on values provided by the Guardian ™ Sensor (3). The Guardian ™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. The Medtronic MiniMed ™ 770G System consists of the following devices: MiniMed ™ 770G Insulin Pump, the Guardian ™ Link (3) Transmitter, the Guardian ™ Sensor (3), one-press serter, the Accu-Chek ® Guide Link blood glucose meter, and the AccuChek ®Guide Test Strips. The MiniMed ™ 770G System includes SmartGuard ™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. The MiniMed ™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. Important Safety Information: MiniMed ™ 770G System With SmartGuard ™ Technology From the System updates menu, select Automatic security updates and turn OFF.
0 kommentar(er)
